An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma - Wikidata - wikimedia - TriplyDB

An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma

An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma

http://www.wikidata.org/entity/Q35122843

about

Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting Perspectives in the treatment of pancreatic adenocarcinoma Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma.FOXP3+ lymphocyte density in pancreatic cancer correlates with lymph node metastasis Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma.A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice.Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer.Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study.Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells.Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling.nab-Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors.Role of immune cells in pancreatic cancer from bench to clinical application: An updated review Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection.Potential approaches for more successful dendritic cell-based immunotherapy.Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models.The impact of dendritic cell-tumor fusion cells on cancer vaccines - past progress and future strategies.Macrophages and pancreatic ductal adenocarcinoma.Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy.Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer.Low intratumoral regulatory T cells and high peritumoral CD8(+) T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy.Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer.Dendritic cell cancer vaccines: from the bench to the bedside.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis.Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC.Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapy.Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers.The Different Functional Distribution of "Not Effector" T Cells (Treg/Tnull) in Colorectal Cancer.Phenotypic and Functional Properties of Tumor-Infiltrating Regulatory T Cells.Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells.T-Cell Immunopeptidomes Reveal Cell Subtype Surface Markers Derived From Intracellular Proteins.When worlds collide: Th17 and Treg cells in cancer and autoimmunity.Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea.Emerging Functions of Regulatory T Cells in Tissue Homeostasis.

P2860

Q26742012-6C3C34B3-6489-4A45-9250-52D83D63703B Q26797248-DCC1F9C4-1B1F-4C6A-9907-0D54223996D5 Q33753714-40D22471-FC74-40F2-923E-65F4596414A8 Q34142307-038451BB-7697-4738-82A4-A0B717F9F50D Q35273555-A5C66704-D05C-40A2-B837-E02DE7FE8553 Q36616446-A2B4D6E0-0148-49DF-A370-DF7EF6A54245 Q36821258-264F1583-0BA9-4EC8-B9CE-E8B48B1A8633 Q37064572-606D4826-3DF3-4BA5-9747-0145964958B7 Q37226075-825174C2-9A47-43E2-A5D9-28B55E160EC9 Q37308216-F5F791A1-2C10-4740-957F-44D5EB62EF85 Q37364111-E0140678-2CEE-41B5-8671-745BE25A8356 Q37536367-BF49CFCB-A2E4-4D64-8B9A-1F9145BC6DA2 Q37606102-944A3B42-70D5-4111-9B87-AA47D3FC762D Q37689086-A2252084-0E62-4F58-A08A-69922B0DAA23 Q38305650-11C8CEFA-F4DA-4811-808C-1CC6D52D08A7 Q38616707-400AEFDF-B339-4221-BFBA-2F8CD5EFDACB Q38617733-2A285029-F533-4692-A682-B811ED87C125 Q38680703-9916A595-AA37-4604-87A2-63F0FA54A8A0 Q39150349-1D1DD457-6DBF-4D09-A8FC-E5D5CA94165D Q39235761-C0C2ED39-9DDB-412B-A2F8-B7E890EB7E39 Q41066538-3137B4CF-40A7-46F5-BFCD-62C6A7EA20DE Q42660198-E0C0A818-0D5C-4D79-9CEC-28C958FE2376 Q42979673-46A471F3-0781-4C79-A9B7-AFD9E4B271E7 Q46540302-AA4F1279-0DEA-4111-AF5B-E510D84421D4 Q47098690-9B2202D9-CAEE-40B2-9E34-1A990E7CFB21 Q47160856-EAC8C21D-61C2-489C-91A6-E17413DAF87F Q47726467-7ED2B75B-296A-4367-8260-18C78FA6E90A Q48146142-DA4ABB5F-041E-4966-9572-03DDCD8031FC Q49322680-E746A189-7D98-4F21-8C7F-7AD4C320594D Q49788536-C89BBC9E-4702-4EB1-AFDF-DD8B496C9298 Q50426810-F201A1F1-B605-4785-B537-B7EAD753872C Q52680130-6330A560-A3BB-4BBD-B65F-F19918F8DC10 Q52689973-AA8B4337-D27C-46CA-8BB3-D4315A7315D7 Q53309734-5675B7CA-5560-4442-B4CC-C48B777A4E72 Q55077356-F06BB389-E6D5-4F85-9541-268A00686157

P2860

An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma

http://www.wikidata.org/entity/Q35122843

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

An increased abundance of tumo ...... ncreatic ductal adenocarcinoma

@ast

An increased abundance of tumo ...... ncreatic ductal adenocarcinoma

@en

type

label

An increased abundance of tumo ...... ncreatic ductal adenocarcinoma

@ast

An increased abundance of tumo ...... ncreatic ductal adenocarcinoma

@en

prefLabel

An increased abundance of tumo ...... ncreatic ductal adenocarcinoma

@ast

An increased abundance of tumo ...... ncreatic ductal adenocarcinoma

@en

P1433

Q35122843-81B084F8-5420-419C-8DF0-7821E978C368

P1476

Q35122843-6DDDAC9C-CC91-41AE-A837-CE6030ABD141

P2093

Q35122843-01314704-3BB5-4B6C-9088-35B6E6315C71

Q35122843-2B64F3FF-46E8-4914-9AE8-6333F3169477

Q35122843-3865DFA8-C480-4D59-B3D0-ABBA785CDBF1

Q35122843-5628D7CF-FB84-4838-9AA4-F931DF37D200

Q35122843-76C75726-F3FA-4675-BE81-493B946BF9FC

Q35122843-9CA349A7-2D46-4234-B009-32D349AC694A

Q35122843-A4CFE658-2ACC-4D1D-8748-53B7C59775D5

Q35122843-A6B8C92F-C2BF-42AE-B065-C675FDC078AA

P2860

Q35122843-007F362A-BE16-43B6-AD69-CC3C8757730F

Q35122843-02B85094-CD74-4188-BB9C-DE445553ED05

Q35122843-0BA94904-23FF-4540-8CE2-79A5EFDBEB3F

Q35122843-0CACF3D7-1D82-46A2-B818-1A9374507C40

Q35122843-0FB27F6E-6A22-41DB-AC99-92819A0FCA60

Q35122843-17FB60BD-C635-4269-89BC-5A6FD887BC61

Q35122843-1ACE35A9-CA9E-4626-BEF6-3C5819126C62

Q35122843-1EF935EF-4A1B-4B27-9FB9-9C052B654FA9

Q35122843-332F574E-2326-4896-A50D-A9A7CB798AF7

Q35122843-349BF9F6-0ABE-4A31-B18C-1552EF2C8882

P304

Q35122843-46831884-CD32-463C-BA34-E856C766FE10

P31

Q35122843-AB23C7CC-2FCE-4887-BCA9-1F8AC6FEF599

P356

Q35122843-E89FED20-0133-42C1-947F-F3FEE18E0AF5

P407

Q35122843-E764A754-C6F1-4835-A10D-0BB0FF0E337C

P433

Q35122843-8242F6A4-5613-4041-8AEE-7938764B1FEE

P478

Q35122843-C7AB2D69-DC47-4E9F-B321-F2704884E22C

P50

Q35122843-FA2DCFB0-A006-431F-B022-BFE54E54565D

P577

Q35122843-6014B3D0-C5FA-4F7E-BA69-C34AD65E65B4

P5875

Q35122843-C0B49FB9-174B-4450-84CF-25F3F432C4CC

P698

Q35122843-76D9CC2E-B39C-4DB6-BA54-E76FE8E12A2E

P921

Q35122843-BBA72590-2C5B-4EED-80DE-7C6577C5549B

P932

Q35122843-48B842DB-72CD-4424-9429-0651EC146DCF

P356

JOURNAL.PONE.0091551

P1433

P1476

An increased abundance of tumo ...... ncreatic ductal adenocarcinoma

@en

P2093

Binfeng Lu

http://www.w3.org/2001/XMLSchema#string

Chaobin Zhang

http://www.w3.org/2001/XMLSchema#string

Huaizhi Wang

http://www.w3.org/2001/XMLSchema#string

Shixiang Guo

http://www.w3.org/2001/XMLSchema#string

Xuejun Xu

http://www.w3.org/2001/XMLSchema#string

Yan Tang

http://www.w3.org/2001/XMLSchema#string

Yi Tian

http://www.w3.org/2001/XMLSchema#string

Yichen Tang

http://www.w3.org/2001/XMLSchema#string

P2860

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

Tregs and rethinking cancer immunotherapy.

Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation

Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancer

IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity.

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

P304

e91551

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0091551

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260874843

http://www.w3.org/2001/XMLSchema#string

P698

24637664

http://www.w3.org/2001/XMLSchema#string

P921

P932

3956642

http://www.w3.org/2001/XMLSchema#string